Depomed, Inc. Begins Phase III Trial for Metformin GR.

Business WireJune 21, 2001

Linked as:

Extract


Depomed, Inc. Begins Phase III Trial for Metformin GR.

Business Editors/Health & Medical Writers

MENLO PARK, Calif.--(BW HealthWire)--June 21, 2001

DepoMed, Inc. (AMEX:DMI) today announced the opening of the investigator...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company